Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methodological Insights from Low-Vacuum SEM for Morphological Analysis of Schwann Cells on Electrospun Scaffolds.

Polymers·2026

Same author

The Role of MNX1-AS1 in Ovarian Cancer Resistance and Tumor Progression via RNA-RNA Interactions.

International journal of molecular sciences·2026

Same author

Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.

EMBO molecular medicine·2026

Same author

THO5 subunit of the Arabidopsis thaliana TREX complex: role in mRNA export and heat tolerance.

Journal of experimental botany·2026

Same author

Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2025

Same author

SARS-CoV-2 nucleocapsid protein variants have differential RNA chaperone activity.

The FEBS journal·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

The Long Non-Coding RNA MALAT1 Modulates NR4A1 Expression through a Downstream Regulatory Element in Specific Cancer

Sara Wernig-Zorc^1,2, Uwe Schwartz³, Paulina Martínez-Rodríguez⁴

¹Regensburg Center for Biochemistry [RCB], Universität Regensburg, 93053 Regensburg, Germany.

International Journal of Molecular Sciences

|May 25, 2024

Summary

The metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) long non-coding RNA fine-tunes NR4A1 gene expression by altering regulatory element accessibility. This mechanism is cell-type specific, observed in breast cancer but not pancreatic cancer.

Keywords:

MALAT1 NR4A1 breast cancer chromatin accessibility chromatin-associated lncRNAs

More Related Videos

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Experiment Videos

Last Updated: Jun 25, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Area of Science:

Molecular Biology
Genomics
Cancer Research

Background:

Long non-coding RNAs (lncRNAs) regulate gene expression and are implicated in cancer.
Limited understanding exists regarding lncRNA effects on gene regulatory elements (REs).

Purpose of the Study:

To investigate how the MALAT1 lncRNA influences gene expression via regulatory elements.
To elucidate the MALAT1/NR4A1 regulatory axis.

Main Methods:

Time-resolved MALAT1 knockdown followed by parallel RNA-seq and ATAC-seq.
CRISPR interference (CRISPR-i) assays.
Analysis of The Cancer Genome Atlas (TCGA) data.
Experimental validation in breast and pancreatic cancer cell lines.

Main Results:

MALAT1 knockdown decreased accessibility downstream of the NR4A1 gene, correlating with reduced NR4A1 expression.
A functional MALAT1/NR4A1 axis was identified, involving an NR4A1-downstream RE.
A positive correlation between NR4A1 expression and RE accessibility was found in breast cancer, but not pancreatic cancer.

Conclusions:

MALAT1 fine-tunes NR4A1 expression by modulating the accessibility of a downstream RE.
This regulatory mechanism is cell type-specific, validated in breast cancer cells (MCF7) but not pancreatic cancer cells (PANC1).